IRIS
SARAO, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.992
AS - Asia 1.912
EU - Europa 988
SA - Sud America 424
AF - Africa 43
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.368
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.936
SG - Singapore 969
CN - Cina 395
BR - Brasile 362
HK - Hong Kong 218
IT - Italia 212
UA - Ucraina 168
VN - Vietnam 146
RU - Federazione Russa 133
DE - Germania 131
IE - Irlanda 71
FI - Finlandia 55
GB - Regno Unito 55
TR - Turchia 48
CA - Canada 33
IN - India 33
SE - Svezia 30
FR - Francia 29
AR - Argentina 24
NL - Olanda 22
AT - Austria 20
PL - Polonia 19
KR - Corea 17
BD - Bangladesh 15
MX - Messico 14
JP - Giappone 13
BE - Belgio 12
ZA - Sudafrica 12
EC - Ecuador 10
ID - Indonesia 9
IQ - Iraq 9
PK - Pakistan 9
PY - Paraguay 7
UZ - Uzbekistan 7
CL - Cile 5
CO - Colombia 5
ES - Italia 5
MA - Marocco 5
TG - Togo 5
AU - Australia 4
KE - Kenya 4
LT - Lituania 4
OM - Oman 4
VE - Venezuela 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
KZ - Kazakistan 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CY - Cipro 2
EU - Europa 2
IS - Islanda 2
LU - Lussemburgo 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MT - Malta 1
NC - Nuova Caledonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
RW - Ruanda 1
SN - Senegal 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 7.368
Salva come PNG Salva come JPEG
Città #
Ashburn 434
Fairfield 428
Woodbridge 377
Singapore 362
Chandler 360
Ann Arbor 283
Houston 245
Beijing 228
Hong Kong 213
Seattle 168
Wilmington 157
Cambridge 132
Boardman 106
Jacksonville 95
Dearborn 75
Princeton 72
Dublin 71
Los Angeles 59
Izmir 45
Ho Chi Minh City 42
New York 41
Dallas 38
Redondo Beach 35
Udine 34
Buffalo 32
Hanoi 29
São Paulo 26
Ogden 25
San Diego 25
Munich 23
Norwalk 23
Dong Ket 22
Warsaw 18
Frankfurt am Main 17
Hefei 17
Santa Clara 17
Seoul 17
Belluno 13
Des Moines 13
Brussels 12
Düsseldorf 12
Belo Horizonte 11
Porto Alegre 11
Rio de Janeiro 11
Wuhan 11
Chicago 10
Phoenix 10
Stockholm 10
Vienna 10
Falls Church 9
Montreal 9
Toronto 9
Amsterdam 8
Bologna 8
Brooklyn 8
Helsinki 8
Lappeenranta 8
Mumbai 8
Redmond 8
Shenzhen 8
Guangzhou 7
Manchester 7
Milan 7
Nanjing 7
Orem 7
Ottawa 7
Paese 7
Rome 7
Tashkent 7
Tokyo 7
Boston 6
Brasília 6
Chengdu 6
Denver 6
Lauterbourg 6
Naples 6
Nuremberg 6
The Dalles 6
Treviso 6
Campinas 5
Grafing 5
Hangzhou 5
Johannesburg 5
Lomé 5
Mexico City 5
Shanghai 5
Turku 5
Chioggia 4
Curitiba 4
Da Nang 4
Guayaquil 4
Jinan 4
Kunming 4
London 4
Mauá 4
Nakano 4
Nanchang 4
Paris 4
Poplar 4
San Francisco 4
Totale 4.832
Salva come PNG Salva come JPEG
Nome #
A case of CRB1-negative Coats-like retinitis pigmentosa 171
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 168
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 167
Proliferative Diabetic Retinopathy: Treatment Update 158
Neovascular age-related macular degeneration 156
Online optical coherence tomography during subthreshold laser irradiation 151
Fluocinolone acetonide for the treatment of diabetic macular edema 151
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 150
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 148
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 147
Dexamethasone implant in diabetic macular edema in real-life situations 144
Optical coherence tomography angiography findings in diabetic retinopathy 143
Author’s response 141
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 141
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 138
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 137
Pharmacotherapy for treatment of retinal vein occlusion. 136
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 133
Triamcinolone acetonide for the treatment of diabetic macular oedema 130
Update on combination therapy in wet age-related macular degeneration 128
Drug safety evaluation of intravitreal triamcinolone acetonide 119
Safety of 6000 intravitreal dexamethasone implants 117
Macular pucker 115
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 113
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 111
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 110
Intravitreal steroids for the treatment of retinal diseases. 109
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 107
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 107
Regression of diabetic macular edema after subcutaneous exenatide. 104
Steroids in a Combination Strategy 101
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 99
Green emission fluorophores in eyes with atrophic age-related macular degeneration: A colour fundus autofluorescence pilot study 95
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 94
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 91
The Present and Future of Optic Pathway Glioma Therapy 89
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 86
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 86
Correction to: Fundamental principles of an effective diabetic retinopathy screening program (Acta Diabetologica, (2020), 57, 7, (785-798), 10.1007/s00592-020-01506-8) 86
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 79
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 78
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 77
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 77
Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study 77
Impact on quality of life 74
Edema maculare post occlusione venosa 72
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 71
Choroidal Thickness Influences Green Emission Autofluorescence Component Intensity in Eyes with Geographic Atrophy Due to Age-Related Macular degeneration: A Color Fundus Autofluorescence Study 69
Stem cell therapy in retinal diseases: current evidence 67
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 67
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 66
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study) 65
Surgical Management for Diabetic Macular Edema 64
Fundamental principles of an effective diabetic retinopathy screening program 62
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 62
Validation of Esaso Classification of Diabetic Maculopathy 61
Present Status of Laser Therapy: Role of Subthreshold Laser 61
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 61
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study) 60
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 58
Does lens influence green component in short 450 nm color autofluorescence? A cross-sectional study in heathy Caucasian population 58
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 55
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 54
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 54
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 54
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI) 53
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 51
Macular Holes 51
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 50
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 50
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 49
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 49
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 49
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 48
Enhancing Diabetic Macular Edema Treatment Outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers 47
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 47
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 47
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 47
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 46
OCT angiography in chronic central serous chorioretinopathy 45
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 44
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 44
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis 40
RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema – How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck Retina 35
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD 35
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 35
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 34
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 33
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey 32
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study 5
RWC Update: Intraocular Inflammation and Retinal Pharmacotherapy; Giant Retinal Tear; ILM Peeling in Myopic Macular Schisis 2
Totale 7.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 0 56 28 70 84 27 52 53
2021/2022451 22 26 9 7 14 22 35 23 18 84 101 90
2022/2023758 96 51 7 121 82 179 0 71 97 4 31 19
2023/2024261 46 17 7 6 35 30 11 26 37 15 2 29
2024/20251.560 27 97 100 76 27 51 113 68 183 138 246 434
2025/20261.859 322 409 276 355 472 25 0 0 0 0 0 0
Totale 7.648